Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for preoperative sedation in preschool children
ChiCTR2400093817Phase 4Recruiting
- Sponsor
- Fuyang People's Hospital
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam in separation anxiety disorder (SAD), sponsored by Fuyang People's Hospital. Primary endpoint: PSAS score at parent-child separation. Started Dec 2024; status: recruiting.
02
Drugs
remimazolam
03
Conditions
separation anxiety disorder (SAD)
Beyond the preview
Go deeper on ChiCTR2400093817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093817.